Kubota Pharmaceutical Holdings Co., Ltd.
OTC: KBBTF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Ryo Kubota
- Employees
- 7
- Headquarters
- Tokyo, Japan
- IPO year
- 2017
- Market cap
- $24.1M
- Website
- https://www.kubotaholdings.co.jp
Loading KBBTF…
Loading profile data…Frequently asked questions about KBBTF
What does Kubota Pharmaceutical Holdings Co., Ltd. (KBBTF) do?
Kubota Pharmaceutical Holdings Co., Ltd. operates globally, concentrating on the development of innovative drugs and medical devices within the ophthalmology sector. A key asset in its product pipeline is emixustat hydrochloride, which is currently undergoing Phase III clinical trials for Stargardt disease and Phase II trials for proliferative d...
Where does KBBTF trade?
Kubota Pharmaceutical Holdings Co., Ltd. (KBBTF) trades on the Other OTC.
What sector is KBBTF in?
Kubota Pharmaceutical Holdings Co., Ltd. (KBBTF) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Kubota Pharmaceutical Holdings Co., Ltd.?
Ryo Kubota is the chief executive officer of Kubota Pharmaceutical Holdings Co., Ltd. (KBBTF).
Where is Kubota Pharmaceutical Holdings Co., Ltd. headquartered?
Kubota Pharmaceutical Holdings Co., Ltd. is headquartered in Japan.
Does KBBTF pay a dividend?
Kubota Pharmaceutical Holdings Co., Ltd. (KBBTF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did KBBTF go public?
Kubota Pharmaceutical Holdings Co., Ltd. (KBBTF) completed its initial public offering in 2017.